TORONTO & LONDON--(BUSINESS WIRE)--Oct 23, 2023--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (鈥� <em>Cybin</em> 鈥�, or the 鈥� <em>Company</em> 鈥�) and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (鈥� <em>Small ...
SAN FRANCISCO--(BUSINESS WIRE)--Oct 23, 2023--Circle Pharma, in collaboration with the laboratory of Violeta Serra, Ph.D., at Vall d鈥橦ebron Institute of Oncology (VHIO) in Barcelona, Spain, recently unveiled preclinical data demonstrating the efficacy of Circle鈥檚 oral Cyclin A/B inhibitor ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 23, 2023--<a ...
BOSTON--(BUSINESS WIRE)--Oct 23, 2023--Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the presentation of updated, positive interim data from its ongoing, open-label Phase 1/1b dose ...
DUBLIN--(BUSINESS WIRE)--Oct 23, 2023--The <a ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct 23, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that initial results from the PEGASUS trial suggest liquid biopsy may be used in post-surgical clinical management to reduce unnecessary toxicity from ...